• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于双氯芬酸钾和低分子量壳聚糖复合物溶解在聚山梨酯中的新型控释液体输送系统。

A new controlled-release liquid delivery system based on diclofenac potassium and low molecular weight chitosan complex solubilized in polysorbates.

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

出版信息

Drug Dev Ind Pharm. 2013 Aug;39(8):1217-29. doi: 10.3109/03639045.2012.707205. Epub 2012 Aug 9.

DOI:10.3109/03639045.2012.707205
PMID:22873834
Abstract

A complex of low molecular weight chitosan (LMWC) with oleic acid and diclofenac potassium (DP) was prepared and dispersed in high concentrations of polysorbate 20, 60 and 80 in water to form a solution which releases its components slowly. The formed complex was characterized using different analytical methods. The size of the resulted nanoparticles and the effect of tweens on size were followed using dynamic light scattering (DLS). The release of DP from this delivery system was monitored by altering the molecular weight of chitosan and the type and concentration of the polysorbates used. The most suitable preparation consisted of DP, LMWC 13 kDa, and oleic acid. This was dispersed in 5% Tween 80 and the release was followed by the adaptation of USP II apparatus using a cellophane bag. This preparation offers a release of up to 24 h.

摘要

一种低分子量壳聚糖(LMWC)与油酸和双氯芬酸钾(DP)的复合物,被制备并分散在高浓度的聚山梨酯 20、60 和 80 中,在水中形成一种缓慢释放其成分的溶液。该复合物通过不同的分析方法进行了表征。使用动态光散射(DLS)跟踪了所得纳米颗粒的大小以及吐温对大小的影响。通过改变壳聚糖的分子量以及聚山梨酯的类型和浓度来监测 DP 从该递药系统中的释放。最合适的制备物由 DP、LMWC(分子量 13 kDa)和油酸组成。将其分散在 5%的吐温 80 中,并通过使用纤维素膜袋适应 USP II 装置来跟踪释放。该制剂可提供长达 24 小时的释放。

相似文献

1
A new controlled-release liquid delivery system based on diclofenac potassium and low molecular weight chitosan complex solubilized in polysorbates.一种基于双氯芬酸钾和低分子量壳聚糖复合物溶解在聚山梨酯中的新型控释液体输送系统。
Drug Dev Ind Pharm. 2013 Aug;39(8):1217-29. doi: 10.3109/03639045.2012.707205. Epub 2012 Aug 9.
2
Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.由刺梧桐树胶-壳聚糖聚电解质复合物制备的双氯芬酸钠控释片的生物药剂学评价
Drug Dev Ind Pharm. 2012 Jul;38(7):815-24. doi: 10.3109/03639045.2011.630006. Epub 2011 Nov 16.
3
Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.用于双氯芬酸钠控释的壳聚糖/卡拉胶珠粒的制备与评价
AAPS PharmSciTech. 2007 Nov 16;8(4):E97. doi: 10.1208/pt0804097.
4
Controlled release of clozapine through chitosan microparticles prepared by a novel method.通过一种新方法制备的壳聚糖微粒实现氯氮平的控释。
J Control Release. 2004 Apr 28;96(2):245-59. doi: 10.1016/j.jconrel.2004.01.025.
5
Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.交联壳聚糖水凝胶珠作为双氯芬酸钠长效递送载体的评价:体内外研究
Boll Chim Farm. 2004 Dec;143(10):359-64.
6
Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.双氯芬酸溶出速率和生物利用度的提高:一种基于壳聚糖的溶剂改变方法。
Int J Pharm. 2008 Feb 28;350(1-2):279-90. doi: 10.1016/j.ijpharm.2007.09.006. Epub 2007 Sep 12.
7
Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.醋氯芬酸壳聚糖微球的体外与体内评价。
Pharm Dev Technol. 2010 Sep-Oct;15(5):442-51. doi: 10.3109/10837450903286503.
8
Preparation and characterization of aspirin/chitosan nanoparticles by nucleation and ionic crosslinking in micro emulsions.微乳液中通过成核和离子交联制备及表征阿司匹林/壳聚糖纳米颗粒
J Control Release. 2011 Nov 30;152 Suppl 1:e39-41. doi: 10.1016/j.jconrel.2011.08.109.
9
Novel chitosan coated magnetic nanocarriers for the targeted Diclofenac delivery.用于靶向递送双氯芬酸的新型壳聚糖包被磁性纳米载体。
J Nanosci Nanotechnol. 2014 May;14(5):3343-7. doi: 10.1166/jnn.2014.8256.
10
Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.用于结肠控释给药的壳聚糖基质的制备及体外评价
J Pharm Pharm Sci. 2003 May-Aug;6(2):274-81.

引用本文的文献

1
Bioactive Potential of Chitosan-Oleic Acid Nanoparticles Loaded with Lemon Peel Essential Oil for Topical Treatment of Vulvovaginal Candidiasis.负载柠檬皮精油的壳聚糖-油酸纳米颗粒用于外阴阴道念珠菌病局部治疗的生物活性潜力
Molecules. 2024 Dec 6;29(23):5766. doi: 10.3390/molecules29235766.
2
Chitin and chitosan as direct compression excipients in pharmaceutical applications.几丁质和壳聚糖作为药物应用中的直接压片辅料。
Mar Drugs. 2015 Mar 19;13(3):1519-47. doi: 10.3390/md13031519.